Search

everythinglearnresearchcommunity

for

Search:↓

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

People with alopecia areata often have thyroid autoimmunity.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.